Lessons Learned from Clinical Trials in Acute Heart Failure: Phase 3 Drug Trials

被引：3
|
作者：
O'Connor, Christopher M. [1 ]
Fiuzat, Mona [1 ]
机构：
[1] Duke Univ, Med Ctr, Div Cardiol, Durham, NC 27710 USA
来源：
HEART FAILURE CLINICS | 2011年 / 7卷 / 04期
关键词：
Acute heart failure; Phase 3 clinical trials; Endpoints; Efficacy; Safety; RANDOMIZED CONTROLLED-TRIAL; ANTAGONIST; ROLOFYLLINE; NESIRITIDE;
D O I：
10.1016/j.hfc.2011.06.013
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Phase 3 clinical trials in acute heart failure are conducted to allow safety and efficacy data to be collected for the evaluation of treatment strategies, including drugs, devices, diagnostics, or nonpharmacological interventions. There are several important features regarding the conduct of phase 3 clinical trials in acute heart failure. This article describes in detail these important aspects of conducting phase 3 clinical trials in an acute heart failure population.
引用
收藏
页码：451 / +
页数：7
相关论文
共 50 条
  • [21] Beyond dyspnoea as an endpoint in acute heart failure trials
    Gheorghiade, Mihai
    Ruschitzka, Frank
    EUROPEAN HEART JOURNAL, 2011, 32 (12) : 1442 - 1445
  • [22] Loop Diuretics Strategies in Acute Heart Failure: From Clinical Trials to Practical Application
    Palazzuoli, Alberto
    Ruocco, Gaetano
    Pellegrini, Marco
    Beltrami, Matteo
    Del Castillo, Gabriele
    Nuti, Ranuccio
    CURRENT DRUG TARGETS, 2015, 16 (11) : 1246 - 1253
  • [23] Lessons learned from recent clinical trials of ketogenic diet therapies in adults
    McDonald, Tanya J. W.
    Cervenka, Mackenzie C.
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2019, 22 (06) : 418 - 424
  • [24] Evaluating Treatment Efficacy by Multiple End Points in Phase II Acute Heart Failure Clinical Trials Analyzing Data Using a Global Method
    Sun, Hengrui
    Davison, Beth A.
    Cotter, Gad
    Pencina, Michael J.
    Koch, Gary G.
    CIRCULATION-HEART FAILURE, 2012, 5 (06) : 742 - 749
  • [25] Trends in use of composite endpoints in clinical trials: A comparison between acute heart failure trials and COVID-19 trials
    Shi, Lan
    Lindsell, Christopher John
    Liu, Dandan
    JOURNAL OF CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 8 (01)
  • [26] Acute Heart Failure: Lessons Learned So Far
    Howlett, Jonathan G.
    CANADIAN JOURNAL OF CARDIOLOGY, 2011, 27 (03) : 284 - 295
  • [27] Acute heart failure: lessons learned, roads ahead
    Ferrari, Roberto
    Bueno, Hector
    Chioncel, Ovidiu
    Cleland, John G.
    Stough, Wendy Gattis
    Lettino, Maddalena
    Metra, Marco
    Parissis, John T.
    Pinto, Fausto
    Ponikowski, Piotr
    Ruschitzka, Frank
    Tavazzi, Luigi
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 (05) : 842 - 850
  • [28] Association between Respiratory Failure and Clinical Outcomes in Patients with Acute Heart Failure: Analysis of 5 Pooled Clinical Trials
    Miller, P. Elliott
    Van Diepen, Sean
    Metkus, Thomas S.
    Alviar, Carlos L.
    Rayner-Hartley, Erin
    Rathwell, Sarah
    Katz, Jason N.
    Ezekowitz, Justin
    Desai, Nihar R.
    Ahmad, Tariq
    JOURNAL OF CARDIAC FAILURE, 2021, 27 (05) : 602 - 606
  • [29] Acute Heart Failure Clinical Drug Development: From Planning to Proof of Activity to Phase III
    Cotter, Gad
    Voors, Adriaan A.
    Weatherley, Beth Davison
    Pang, Peter S.
    Teerlink, John R.
    Filippatos, Gerasimos
    Ponikowski, Piotr
    Milo-Cotter, Olga
    Dittrich, Howard
    Teichman, Sam L.
    Adams, Kirkwood F.
    Gheorghiade, Mihai
    Metra, Marco
    CARDIOLOGY, 2010, 116 (04) : 292 - 301
  • [30] End-Point Selection for Acute Heart Failure Trials
    Allen, Larry A.
    HEART FAILURE CLINICS, 2011, 7 (04) : 481 - +
12345